ADAMTS15 and prostate cancer: To further investigate the role of ADAMTS-15 in prostate cancer, LNCaP and PC-3 cell lines were used as representative early-stage ‘androgen-responsive’ and late-stage ‘castrate-resistant’ prostate cancer cells, respectively [37].